Search
for
Sort by
Research 211–240 of 355
- Risk of Alopecia Areata with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- Abstract 4142154: Risk of Suicide, Hair Loss, and Aspiration with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Pharmacovigilance Study from the FAERS database
- Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review
- Association Between Androgenetic Alopecia and Glucagon‐Like Peptide‐1 Receptor Treatment in Type 2 Diabetes Mellitus Patients: A Retrospective Cohort Study
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications
- Peptide Therapy in Aesthetic, Metabolic, and Endocrine Medicine
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- Maternal obesity and the metabolic syndrome in reproductive health: assessing incretin-based interventions
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Methylene blue protects hair follicle stem cells from oxidative and metabolic stress to enhance hair regeneration
- Effects of GLP ‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
- Performing a Nonsurgical Hair Restoration Consultation
- Abstracts from the 2024 WDS Forum - virtual option
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Editor's Highlights — September 2024
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Pseudoglucagonoma syndrome secondary to pancreatitis: A case report
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- Pseudoglucagonoma Syndrome Following Frey’s Surgery: A Case Report of a Rare Presentation
- Persistent Hypoglycemia and Macrosomia in a Newborn
- Necrolytic Migratory Erythema in a Cat with Glucagonoma Syndrome
- Pharmacodynamic Evaluation: Endocrinology